#Flash: Biological E gets DCGI nod for Ph 2/3 Clinical Trial
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
DCGI approved Biological E Limited of Hyderabad to conduct phase 2/3 clinical trials of its "Made in India" COVID-19 vaccine on children aged 5 to 18 years with certain conditions on Wednesday. The trial will take place in 10 different locations around the country. In June, the government revealed that it had made a Rs 1,500 crore advance payment to Biological E for the 30 crore vaccines.

If you find this research insightful, please like, comment and share.

For more details please read here: https://health.economictimes.indiatimes.com/news/diagnostics/dcgi-gives-nod-for-phase-2/3-trials-of-biological-es-covid-vaccine-on-those-aged-between-5-18/85862578
Like
Comment
Share